Zhengzhou, China

Hui Liu

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Chinese Academy of Agricultural Sciences, Safekey Engineering Technology (Zhengzhou), Ltd.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hui Liu. Retrieved from https://idiyas.com/inventor/hui-liu-ocbz4k5o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 33.3

Average Co-Inventor Count = 8.1

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovation and Impact: The Patents of Inventor Hui Liu

Introduction: Hui Liu, an accomplished inventor based in Zhengzhou, China, has made significant contributions to the field of natural active compounds through his innovative work. With a total of four patents to his name, his latest inventions focus on developing compositions that enhance hypoglycemic applications by inhibiting alpha-glucosidase, potentially transforming therapeutic approaches in diabetes management.

Latest Patents: Hui Liu's most recent patents include:

1. **Composition Containing Hesperetin and Synergistic Hypoglycemic Application Thereof** - This innovation discloses a composition combining hesperetin with a compound X, which may be either galangin or formononetin. The specific mass ratios are 30:100 for hesperetin to galangin and 30:20 for hesperetin to formononetin. This composition demonstrates a significant synergistic effect in inhibiting α-glucosidase, outperforming the effects of the flavonoid compound used alone. Consequently, this may lead to reduced drug dosages and lower instances of drug resistance.

2. **Composition for Inhibiting Alpha-Glucosidase and Application Thereof** - Another groundbreaking invention by Liu, this patent encompasses a composition that includes daidzein and quercetin derivatives (taxifolin or 3-O-methyl quercetin). The optimal mass ratios are established as 8:25-10:25 for daidzein to taxifolin and 8:2-8:4 for daidzein to 3-O-methyl quercetin. The synergistic nature of these compounds results in enhanced inhibition of α-glucosidase, reinforcing the potential for effective drug therapy with minimized resistance risks.

Career Highlights: Hui Liu is affiliated with the Chinese Academy of Agricultural Sciences, where he conducts research aimed at developing natural solutions for health-related issues. His focus on the application of natural compounds highlights his commitment to improving public health through innovative scientific research.

Collaborations: Throughout his career, Hui Liu has collaborated with notable colleagues such as Zhonggao Jiao and Jiechao Liu. Their combined expertise and efforts emphasize the importance of teamwork in advancing research and fostering innovations in the field.

Conclusion: Hui Liu exemplifies the spirit of innovation within the realm of natural active compounds. His patents are a testament to his dedication to finding effective solutions for health challenges. By harnessing the power of nature, Liu continues to pave the way for advancements that promise to enhance therapeutic options and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…